Evidence map›Paper›PMID 30257953›Full record

ArticleScience translational medicine2018

Gallium disrupts bacterial iron metabolism and has therapeutic effects in mice and humans with lung infections.

Christopher H Goss, Yukihiro Kaneko, Lisa Khuu, Gail D Anderson, Sumedha Ravishankar, Moira L Aitken, Noah Lechtzin, Guolin Zhou, Daniel M Czyz, Kathryn McLean and 11 more

Abstract readClinical Trial, Phase I
In one paragraph

Article in Science translational medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 153 papers.

0numbers the graph read from it
0cells of the map it votes in
153citing papers in PubMed
22.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

153 citing papers in PubMed, 344 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Strontium and gallium doping enhancesMaterials today. Bio · 2026
    Article
  9. Experimental and DFT Investigation of a Vitamin BSensors (Basel, Switzerland) · 2026
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article

93 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 7 institutions in 2 countries.

Christopher H GossDepartment of Medicine, University of Washington School of Medicine, Seattle, WA 98195, USA.ORCID 0000-0001-8602-0309
Yukihiro KanekoDepartment of Bacteriology, Osaka City University School of Medicine, Osaka 545-0051, Japan.
Lisa KhuuDepartment of Microbiology, University of Washington School of Medicine, Seattle, WA 98195, USA.ORCID 0000-0001-6511-7814
Gail D AndersonDepartment of Pharmacy, University of Washington School of Pharmacy, Seattle, WA 98195, USA.
Sumedha RavishankarDepartment of Microbiology, University of Washington School of Medicine, Seattle, WA 98195, USA.ORCID 0000-0002-4026-0742
Moira L AitkenDepartment of Medicine, University of Washington School of Medicine, Seattle, WA 98195, USA.
Noah LechtzinDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.ORCID 0000-0002-9088-8749
Guolin ZhouBen May Department for Cancer Research, University of Chicago, Chicago, IL 60637, USA.
Daniel M CzyzDepartment of Microbiology, The University of Chicago, Chicago, IL 60637, USA.
Kathryn McLeanDepartment of Laboratory Medicine, University of Washington School of Medicine, Seattle, WA 98195, USA.ORCID 0000-0001-7986-0879
Oyebode OlakanmiUniversity of Cincinnati College of Medicine, Cincinnati, OH 45267, USA.
Howard A ShumanDepartment of Microbiology, The University of Chicago, Chicago, IL 60637, USA.ORCID 0000-0001-7955-8709
Mary TeresiDepartment of Medicine, University of Nebraska School of Medicine, Omaha, NE 68105, USA.
Ellen WilhelmDepartment of Medicine, University of Washington School of Medicine, Seattle, WA 98195, USA.ORCID 0000-0002-9928-8221
Ellen CaldwellDepartment of Medicine, University of Washington School of Medicine, Seattle, WA 98195, USA.
Stephen J SalipanteDepartment of Laboratory Medicine, University of Washington School of Medicine, Seattle, WA 98195, USA.ORCID 0000-0001-8355-6992
Douglas B HornickDepartment of Medicine, University of Nebraska School of Medicine, Omaha, NE 68105, USA.
Richard J SiehnelDepartment of Microbiology, University of Washington School of Medicine, Seattle, WA 98195, USA.ORCID 0000-0001-7078-5657
Lev BeckerBen May Department for Cancer Research, University of Chicago, Chicago, IL 60637, USA.
Bradley E BritiganDepartments of Medicine and Pediatrics, University of Iowa, Iowa City, IA 52242, USA.
Pradeep K SinghDepartment of Microbiology, University of Washington School of Medicine, Seattle, WA 98195, USA. singhpr@uw.edu.ORCID 0000-0001-9281-0219
University of Washington · USUniversity of Chicago · USUniversity of Nebraska at Omaha · USJohns Hopkins University · USOsaka City University · JPUniversity of Cincinnati Medical Center · USUniversity of Iowa · US

Funding

Translational Research Center to Expedite Novel Therapies in Cystic FibrosisP30DK089507 · NIDDK · SEATTLE CHILDREN'S HOSPITAL · PI PRADEEP k SINGH · 2010 to 2026
$21.4M
Proof of Principle Evaluation of IV Gallium Nitrate in Patients with CFUM1HL119073 · NHLBI · UNIVERSITY OF WASHINGTON · PI GOSS, CHRISTOPHER HOOPER, SINGH, PRADEEP K · 2013 to 2017
$4.8M
Investigating treatment resistance mechanisms in chronic bacterial infectionsR01AI101307 · NIAID · UNIVERSITY OF WASHINGTON · PI BRUCE, JAMES EDWARD, MANOIL, COLIN · 2012 to 2016
$2.9M
Phase 2 Study of Intravenous Gallium Nitrate in the Treatment of Cystic FibrosisR01FD003704 · FDA · UNIVERSITY OF WASHINGTON · PI GOSS, CHRISTOPHER HOOPER · 2009 to 2018
$2.0M
Studies on bacterial populations and therapeutics for CF lung infectionsK24HL102246 · NHLBI · UNIVERSITY OF WASHINGTON · PI SINGH, PRADEEP K · 2010 to 2019
$1.6M
Gallium, a potential new therapeutic for CF airway infectionsR01HL085868 · NHLBI · UNIVERSITY OF WASHINGTON · PI SINGH, PRADEEP K · 2009 to 2010
$907k
FDA HHS R01 FD003704NHLBI NIH HHS K24 HL102246NHLBI NIH HHS R01 HL085868NHLBI NIH HHS UM1 HL119073NIAID NIH HHS R01 AI101307NIDDK NIH HHS P30 DK089507
6 · The paper itself

Abstract

The lack of new antibiotics is among the most critical challenges facing medicine. The problem is particularly acute for Gram-negative bacteria. An unconventional antibiotic strategy is to target bacterial nutrition and metabolism. The metal gallium can disrupt bacterial iron metabolism because it substitutes for iron when taken up by bacteria. We investigated the antibiotic activity of gallium ex vivo, in a mouse model of airway infection, and in a phase 1 clinical trial in individuals with cystic fibrosis (CF) and chronic

Indexed as

AdolescentAdultAnimalsAnti-Bacterial AgentsBacterial ProteinsCystic FibrosisDNA Transposable ElementsDrug Resistance, BacterialDrug SynergismGalliumGenes, BacterialHumansIronLungMacrophagesMice, Inbred C57BLAnti-Bacterial AgentsBacterial ProteinsDNA Transposable ElementsGalliumIronOxidants

Identifiers

PMID30257953
PMCPMC6637966
OpenAlexW2893806747

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.